Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  GlaxoSmithKline    GSK   GB0009252882

GLAXOSMITHKLINE

(GSK)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Most relevant news about GLAXOSMITHKLINE
2018GLAXOSMITHKLINE : Backs 2018 Dividend Guidance, Swings to 4Q Net Loss
DJ
2018GLAXOSMITHKLINE : GSK delivers improvements in sales, margins and cash flow in 2..
PU
2018GLAXOSMITHKLINE : GSK's meningitis B vaccine Bexsero receives Breakthrough Thera..
PU
2018GLAXOSMITHKLINE : GSK's Bexsero FDA Breakthrough Therapy Designation
PU
2018Glaxo, Reckitt Submit Sole Bids for Pfizer's Consumer Unit -Bloomberg
DJ
2018Take Five - World markets themes for the week ahead
RE
2018UK stocks end two days of currency-driven declines
RE
2018GLAXOSMITHKLINE : GSK's Shingrix receives positive opinion from the CHMP in Euro..
PU
2018GLAXOSMITHKLINE : GSK's Shingrix - positive CHMP opinion in Europe
PU
2018GLAXOSMITHKLINE : GSK's Relvar Ellipta - positive CHMP opinion
PU
2018GLAXOSMITHKLINE : GSK Announces CHMP Positive Opinion for Labelling Update to Re..
BU
2018AstraZeneca's 3-in-1 inhaler helps COPD patients in trial
RE
2018Exclusive - J&J out of race for Pfizer's $20 billion consumer unit as deadlin..
RE
2018EXCLUSIVE : J&J out of race for Pfizer's $20 billion consumer unit as deadline l..
RE
2018GLAXOSMITHKLINE : GSK responds to the AMR Benchmark
PU
2018Drug companies told to do more to tackle 'superbug' crisis
RE
2018En route to Davos, Macron makes Versailles the place to be
RE
2018At AstraZeneca, fewer drug projects bring big productivity jump
RE
2018ASPEN PHARMACARE : Drugmaker GSK cuts back in Africa to hone emerging markets mo..
RE
2018Drugmakers see a pricing blueprint in an $850,000 gene therapy
RE
2018GLAXOSMITHKLINE : GSK CEO says looking at Pfizer consumer business, but not a pr..
RE
2018Rivals Help Fund Regeneron's Gene-Sequencing Effort
DJ
2017GLAXOSMITHKLINE : FDA approves US label update on ICS/LABA combinations in asthm..
PU
2017GLAXOSMITHKLINE : FDA approval - on ICS/LABA combinations in asthma
PU
2017GLAXOSMITHKLINE : boosts stake in Saudi Arabia unit
RE
2017GLAXOSMITHKLINE : Transfer of Shares out of Treasury
PU
2017GLAXOSMITHKLINE : GSK Applies for Australian Approval of Malaria Treatment
DJ
2017GLAXOSMITHKLINE : GSK submits regulatory application for single-dose tafenoquine..
PU
2017GLAXOSMITHKLINE : GSK achieves approval for Nucala (mepolizumab) for the treatme..
PR
2017GLAXOSMITHKLINE : GSK gains US approval for Nucala to treat EGPA
PU
2017GLAXOSMITHKLINE : GSK achieves approval for Nucala (mepolizumab) for the treatme..
PU
2017GLAXOSMITHKLINE : Encouraged By Blood-Cancer Drug Study
DJ
2017GLAXOSMITHKLINE : Promising data for GSK2857916 at ASH meeting
PU
2017GLAXOSMITHKLINE : Nucala gets FDA Approval for EGPA
DJ
2017GLAXOSMITHKLINE : GSK presents promising new data for priority BCMA asset from i..
PU
2017GSK's new pharma head on lookout for cancer deals to boost pipeline
RE
2017Companies prepare for disorderly Brexit as talks stall
RE
2017GSK, other drugmakers bet on post-Brexit UK science
RE
2017GLAXOSMITHKLINE : New data supports the safety and efficacy of GSK's Shingrix in..
PU
2017GLAXOSMITHKLINE : GSK welcomes launch of the UK Government's Life Sciences Secto..
PU
2017GLAXOSMITHKLINE : New data - Shingrix in immune-compromised patients
PU
2017Australian watchdog takes GlaxoSmithKline, Novartis units to court
RE
2017FTSE falls in broad risk-off move as Trump worries resurface
RE
2017GLAXOSMITHKLINE : ViiV Healthcare announces start of phase III study of long-act..
PU
2017GLAXOSMITHKLINE : ViiV starts Phase 3 HIV prevention study in women
PU
2017European shares gain, led by retailers, financials; FTSE lags
RE
2017GLAXOSMITHKLINE : GSK submits US regulatory application for single-dose tafenoqu..
PU
2017Oil prices, China jitters weigh on Britain's blue-chips
RE
2017GLAXOSMITHKLINE : ViiV Healthcare starts third phase III HIV treatment study inv..
PU
2017GLAXOSMITHKLINE : GSK responds to UK Industrial Strategy
PU
2017GLAXOSMITHKLINE : ViiV starts Phase 3 longacting HIV treatment study
PU
2017ASTRAZENECA : steps up China push with new drug joint venture
RE
2017GLAXOSMITHKLINE : Files Additional Trelegy Ellipta Application to FDA
DJ
2017GLAXOSMITHKLINE : GSK submit IMPACT data to support Trelegy Ellipta
PU
2017GLAXOSMITHKLINE : GSK Submits Landmark IMPACT Data to US Regulatory Authority to..
BU
2017U.S. FDA approves first two-drug HIV regimen in win for GSK
RE
2017GLAXOSMITHKLINE : ViiV Juluca approved in US as first 2-drug regimen
PU
2017GLAXOSMITHKLINE : GSK publishes 2018 dividend dates
PU
2017Brexit gets real for drugmakers as regulator moves to Amsterdam
RE
2017ASTRAZENECA : EU drugs agency move to Amsterdam minimizes likely staff losses
RE
2017ASTRAZENECA : EU drugs agency move to Amsterdam minimises likely staff losses
RE
2017Europe approves GlaxoSmithKline's new triple lung drug
RE
2017GLAXOSMITHKLINE : Trelegy Ellipta EU approval for treatment of COPD
PU
2017GLAXOSMITHKLINE : Trelegy Ellipta Once-Daily Single Inhaler Triple Therapy Gains..
BU
2017Gates Foundation, Abu Dhabi Pair to Fight Forgotten Diseases -- Update
DJ
2017BILL GATES : Gates Foundation, Abu Dhabi Pair to Fight Forgotten Diseases
DJ
2017Bayer hires new blood to stem 'Amazon effect' in consumer health
RE
2017GLAXOSMITHKLINE : GSK receives European marketing authorisation for self-injecta..
PU
2017GLAXOSMITHKLINE : Receives European Authorization for Self-Injectable Benlysta
DJ
2017GLAXOSMITHKLINE : Block listing Interim Review
PU
2017Falls in Burberry, housebuilders pile pressure on FTSE
RE
2017ASTRAZENECA : rides China wave as rival GlaxoSmithKline struggles
RE
2017Thousands of drugs face Brexit risk, makers to duplicate testing
RE
2017Hikma in dispute with FDA over generic Advair, cuts generics sales forecast a..
RE
2017Hikma, Vectura in dispute with FDA over generic Advair
RE
Prev.5  6  7  8  9   10  11  12  13  14Next
Upcoming event on GLAXOSMITHKLINE